Delaware Health News Online: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Delaware Health News Online.

Press releases published on November 13, 2026

Nov. 13, 2026

Nanox Announces Distribution Agreement with Medworks for Nanox.AI in Greece

Indeterminate GlobeNewswire

Nov. 13, 2026

Allarity Therapeutics Reports Third Quarter 2026 Results and Provides Full Year 2026 Financial Guidance

Indeterminate GlobeNewswire

Nov. 13, 2026

Biofrontera Inc. Reports Strong Third Quarter 2026 Financial Results Driven by 30% Year-Over-Year Revenue Growth

Indeterminate GlobeNewswire

Nov. 13, 2026

Annovis Provides Corporate Updates and Reports Third Quarter 2026 Financial Results

Indeterminate GlobeNewswire

Nov. 13, 2026

Madrigal Pharmaceuticals Announces Participation at Three Upcoming Investor Conferences

Indeterminate GlobeNewswire

Nov. 13, 2026

Fortress Biotech Reports Third Quarter 2026 Financial Results and Recent Corporate Highlights

Indeterminate GlobeNewswire

Nov. 13, 2026

Benitec Biopharma Releases First Quarter 2027 Fiscal-Year Financial Results and Provides Operational Update

Indeterminate GlobeNewswire

Nov. 13, 2026

Aardvark Therapeutics Reports Third Quarter 2026 Financial Results and Provides Business Updates

Indeterminate GlobeNewswire

Nov. 13, 2026

IRulya Therapeutics Provides Corporate Update and Reports Third Quarter 2026 Financial Results

Indeterminate GlobeNewswire

Nov. 13, 2026

PDS Biotech Reports Third Quarter 2026 Financial Results

Indeterminate GlobeNewswire

Nov. 13, 2026

Surrozen Announces Pricing of $60 Million Underwritten Offering of Common Stock

Indeterminate GlobeNewswire

Nov. 13, 2026

GH Research Reports Third Quarter 2026 Financial Results and Provides Business Update

Indeterminate GlobeNewswire

Nov. 13, 2026

GH Research Announces Appointment of Vanina Popova, MD, as Chief Development Officer

Indeterminate GlobeNewswire

Nov. 13, 2026

Milestone Scientific Reports Financial Results for Third Quarter 2026

Indeterminate GlobeNewswire

Nov. 13, 2026

Milestone Pharmaceuticals Reports Third Quarter 2026 Financial Results and Announces Cost-Efficiency Measures Designed to Extend Cash Runway Through AFib-RVR Phase 3 Data

Indeterminate GlobeNewswire

Nov. 13, 2026

Joint replacement in Charleston: a credentials checklist for choosing an orthopedic surgeon

Indeterminate GlobeNewswire

Nov. 13, 2026

Contract Terms Shape How Quickly Outsourced Customer Support Can Scale Down After a Seasonal Spike

Indeterminate GlobeNewswire

Nov. 13, 2026

Tvardi Therapeutics Announces Third Quarter 2026 Results and Provides Business Update

Indeterminate GlobeNewswire

Nov. 13, 2026

BioCryst Presents New Real-World Evidence Showing Reduced Angioedema-Related Medical Visits After Switching to ORLADEYO® (berotralstat) at ACAAI 2026 Annual Scientific Meeting

Indeterminate GlobeNewswire

Nov. 13, 2026

Jade Biosciences Reports Third Quarter 2026 Financial Results and Provides Corporate Update

Indeterminate GlobeNewswire